Krishna Chotneeru

Krishna Chotneeru, MS, MPH, holds extensive experience in the pharmaceutical and healthcare sectors, currently serving as Associate Director at Alnylam Pharmaceuticals since January 2018, with roles including Associate Director on Expat Assignment and Senior Manager. Prior positions include Principal Analyst and Senior Analyst at Novartis from September 2013 to December 2017, and Senior Analyst at Ockham Development Group consulting for Genzyme from March 2010 to September 2013. Earlier career stages featured roles as Statistical Analyst at INC Research and Quintiles. Krishna's educational background includes a Master of Public Health with focuses in Health Policy Management, Biostatistics, and Epidemiology from the University of North Carolina at Chapel Hill, a Master of Science in Electrical and Electronics Engineering from Wayne State University, and completion of the CORe Credential of Readiness from Harvard Business School Online, among other qualifications in global market access and biomedical engineering.